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The high burden of inpatient diabetes 
mellitus: the Melbourne Public Hospitals 
Diabetes Inpatient Audit
Abstract 
Objective: To determine the prevalence of diabetes in inpatients in Melbourne 
hospitals.
Design: Point prevalence survey of all inpatients in each hospital on a single day 
between 30 November 2010 and 22 November 2012.
Setting: 11 hospitals in metropolitan Melbourne including community, secondary 
and tertiary hospitals and one aged care and rehabilitation centre.
Participants: 2308 adult inpatients in all wards apart from intensive care, 
emergency, obstetrics and psychiatry.
Main outcome measures: Point prevalence of self-reported diabetes, details of 
current medication, self-reported frequency of complications.
Results: Diabetes status was obtained in 2273 of 2308 inpatients (98.5%). 
Of these, 562 (24.7%) had diabetes (95% CI, 22.9%–26.5%). Diabetes 
prevalence ranged from 15.7% to 35.1% in diff erent hospitals (P < 0.001). 
Patients with diabetes were older, heavier and more likely to be taking lipid-
lowering, antihypertensive and blood-thinning medications. Of 388 patients with 
complete medication information, 270 (69.6%) were taking oral hypoglycaemic 
agents alone or in combination with insulin, 158 (40.7%) were treated with 
insulin (67 [17.3%] with insulin alone) and 51 (13.1%) were not taking medication 
for diabetes. The frequency of diabetes complications was very high: 207/290 
(71.4%) for any microvascular complication, 275/527 (52.2%) for any 
macrovascular complication and 227/276 (82.2%) for any complication.
Conclusion: The high burden of diabetes in Melbourne hospital inpatients has 
major implications for patient health and health care expenditure. Optimising 
care of these high-risk patients has the potential to decrease inpatient morbidity 
and length of stay as well as preventing or delaying future complications. A 
formal Australian national audit of inpatient diabetes would determine its 
true prevalence and consequences, allowing rational planning to deal with 
shortcomings in its management.
The prevalence of diabetes mellitus in the Australian community is high and in-
creasing rapidly.1-3 Diabetes and 
its complications cause substantial 
morbidity and premature mortality, 
and account for a signifi cant propor-
tion of total health expenditure. For 
example, patients with diabetes in 
the United States account for US$123 
billion or 26% of inpatient expendi-
ture.4 The prevalence of diabetes in 
adult inpatients ranges from 5.8% 
to 26.2% in the US, United Kingdom 
and Japan,5-7 but there are currently 
no equivalent Australian data. We 
therefore undertook a survey to de-
termine the prevalence of diabetes in 
inpatients in 11 hospitals in metro-
politan Melbourne, which included 
community, secondary and tertiary 
hospitals and one aged care and re-
habilitation centre. We compared 
demographic parameters between 
patients with and without diabe-
tes, and collected more detailed in-
formation about management and 
complications from patients with 
diabetes.
Methods
Point prevalence patient surveys were 
conducted in 11 Melbourne metro-
politan hospitals, each on a single day 
between 30 November 2010 and 22 
November 2012. The study was ap-
proved by the human research ethics 
committees of each centre.
Adult inpatients in all wards except 
intensive care, emergency, obstetrics 
and psychiatry were surveyed us-
ing a scripted interview. Patients 
were interviewed unless they were 
absent, too unwell to respond or in-
suffi ciently profi cient in English. In 
these cases, medical records were 
used. Patients were questioned about 
diabetes status, family history of dia-
betes, age > 40 years and medications 
(lipid-lowering, antihypertensive 
and blood-thinning medication and 
glucocorticoids). 
Patients with diabetes were asked 
about duration and type of diabetes, 
treatment, medical management, 
diabetes and dietetic education, sur-
veillance and prevalence of complica-
tions, and smoking.
Hospital data are shown sepa-
rately except for Eastern Health 
which includes Box Hill, Maroondah 
and Angliss Hospitals. Ten of 
Melbourne’s 19 adult general hos-
pitals participated, including four 
of fi ve major tertiary teaching hos-
pitals (The Alfred, Austin, Monash 
and St Vincent’s) as well as six other 
teaching and community hospitals 
(Eastern, Sandringham, Sunshine 
and Western). One of eight rehab-
ilitation hospitals also participated 
(Caulfi eld).
To validate self-reported diabetes 
diagnoses, diabetes status was con-
fi rmed in medical records of 10% 
of patients in each hospital. Three 
patients were misclassifi ed (two with-
out and one with diabetes), indicating 
an accuracy of 98.7%. Self-reported 
admission diagnoses matched those 
on the discharge summary in 90%–
95% of a subset of patients.
Statistics
Continuous data are shown as mean 
(95% CI). Unpaired t tests or one-way 
analyses of variance were used to 
compare groups as appropriate. For 
categorical data, proportions were 
analysed using χ 2 tests with conti-
nuity correction where appropri-
ate, followed by unadjusted z tests 
to compare individual proportions. 
Sandringham was excluded from 
some prevalence ranges for individ-
ual hospitals as only eight patients 
had diabetes. Binomial exact methods 
were used to calculate 95% confi dence 
intervals for proportions. Pearson 
correlation between community and 
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hospital prevalence of diabetes was 
calculated. Analyses were performed 
using IBM SPSS Statistics version 20.
Results
Of 2311 patients approached, three 
patients declined to participate and 
the remaining 2308 were interviewed 
or their medical records were used. 
Data were 69.4%–85.6% complete for 
individual questions apart from dia-
betes diagnosis (98.5%). Additionally, 
weight was available for 1604 (69.5%) 
and age for 583 patients (25.3%). Data 
from patients with diabetes were 
61.6%–100.0% complete for individ-
ual questions. Diabetes status was 
obtained in 2273 of 2308 inpatients 
(98.5%). Of these, 562 (24.7%) had di-
abetes (95% CI, 22.9%–26.5%), with 
hospital prevalences ranging from 
15.7% to 35.1% (Box 1, P < 0.001).
Associations with diabetes
A family history of diabetes was 
noted in 174 of 323 patients with 
diabetes (53.9%) compared with 356 
of 1354 patients without diabetes 
(26.3%) (P < 0.001). Patients with dia-
betes were more likely to be over 40 
years old (94.3% v 80.6%, P < 0.001) 
and were older than patients without 
diabetes (mean age, 72.4 years; 95% 
CI, 70.3–74.4 years v 67.5 years; 95% 
CI, 65.6–69.4 years; n = 583; P = 0.001). 
Patients with diabetes were heavier 
(mean weight, 80.8 kg; 95% CI, 78.8–
82.7 kg v 73.6 kg; 95% CI, 72.6–74.6 kg; 
P < 0.001), and more likely to be tak-
ing lipid-lowering (60.6% v 28.3%, 
P < 0.001), antihypertensive (67.7% v 
44.6%, P < 0.001) and blood-thinning 
medication (60.2% v 40.8%, P < 0.001). 
Surprisingly, glucocorticoid use was 
similar in patients with and without 
diabetes (18.9% v 15.2%, P = 0.10).
Patients with diabetes
Mean duration of diabetes was 11.9 
years (95% CI, 10.9–13.0 years) with no 
difference between hospitals (n = 334; 
P = 0.62). Of 474 patients with record-
ed diabetes type, 91.8% had type 2 
diabetes (range between hospitals, 
83.3%–98.1%; lowest, The Alfred; 
highest, Western and Sunshine; 
P = 0.001) and 4.9% had type 1 dia-
betes (range, 0–8.6%). Cystic fi bro-
sis-induced diabetes accounted for 
fi ve cases (1.1%) and glucocorticoid-
induced diabetes accounted for seven 
(1.5%). It is likely that glucocorticoid-
induced diabetes was underreported 
since patients may not recognise the 
link between glucocorticoid use and 
diabetes.
Admission diagnosis was record-
ed in 404 patients with diabetes. 
Of these, only four had a diagnosis 
directly related to problems with 
glycaemic control. Cardiovascular 
disease accounted for 59 admissions. 
Of 82 patients admitted with infec-
tions, 21 had respiratory infections, 
17 had skin and/or foot infections 
and 10 had genitourinary infections. 
Forty patients were admitted for dia-
betes-related surgery (peripheral vas-
cular disease surgery, foot surgery, 
coronary artery bypass grafting, en-
darterectomy or renal failure-related 
surgery) and 71 for surgery unrelated 
to diabetes. Five admissions related 
to transplantation, and other indica-
tions accounted for the remaining 147.
Complete information on diabe-
tes medication was available in 388 
patients. Oral hypoglycaemic agents 
were used by 270 patients (69.6%; 
range, 58.2%–86.8%, P < 0.001; low-
est, The Alfred; highest, Sunshine). 
Insulin was used by 158 patients 
(40.7%; range, 31.8%–55.3%, P = 0.12), 
91 with oral agents (23.5%; range, 
13.6%–42.1%, P < 0.001; lowest, 
Eastern; highest, Sunshine) and 67 
without oral agents (17.3%). The re-
maining 51 patients (13.1%) were 
not recorded as taking any diabetic 
medication.
In 227 patients with relevant infor-
mation, 96 (42.3%) took metformin 
alone, 54 (23.8%) a sulfonylurea alone, 
and 57 (25.1%) took both, with no dif-
ference between hospitals (P = 0.32). 
The remaining 20 patients took thia-
zolidinediones, dipeptidyl peptidase 
4 (DPP4) inhibitors or acarbose alone 
or in combination with metformin or 
a sulfonylurea. Insulin delivery was 
noted in 189 patients; 168 used pens 
(88.9%; range, 64.3%–96.6%, P = 0.06), 
18 (9.5%) used syringes and three 
(1.6%) used a pump.
Of 495 patients, 331 (66.9%); range, 
50.0%–80.5%, P = 0.006; highest 
Western, Sunshine) were managed by 
their general practitioners and three 
(0.6%) had no medical input; the re-
mainder were managed by specialists 
in private practice or in outpatient 
clinics. Diabetes education was re-
ported in 258 of 424 patients (60.8%; 
range, 50.0%–72.1%, P = 0.48) and 241 
of 437 patients (55.1%; range, 49.3%–
83.3%, P = 0.005; lowest, Sunshine; 
highest, Caulfi eld) had seen a dieti-
tian. Most patients monitored home 
blood glucose levels (347/427, 81.3%; 
range, 66.7%–91.9%, P = 0.03; lowest, 
The Alfred; highest, Eastern).
Complications surveillance
Eye checks were reported in 360 of 449 
patients, (80.2%; range, 69.2%–100%, 
P = 0.59) whereas only 62.9% recalled 
urine testing to assess kidney damage 
(range, 13.0%–82.1%, P < 0.001; lowest, 
St Vincent’s; highest, Caulfi eld). Foot 
care in the previous year was report-
ed in 296 of 451 patients (65.6%; range, 
50%–69.8%, P = 0.42). Two hundred 
1  Diabetes prevalence (95% CI) in inpatients at Melbourne metropolitan 
hospitals
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and fi fty-seven of 474 patients (54.2%; 
range, 33.3%–61.9%, P = 0.63) had ever 
smoked, whereas 38 of 483 patients 
(7.9%; range, 1.9%–13.7%, P = 0.13) 
were current smokers.
The prevalence of microvascular 
complications was high, with 207 
of 290 patients (71.4%; range, 61.8%–
78.9%, P = 0.43) reporting at least one 
complication. Kidney damage was 
reported in 113 of 278 patients (40.6%; 
range, 26.4%–53.4%, P = 0.05; lowest, 
Western; highest, Monash), and eye 
damage was reported in 112 of 271 
(41.3%; range, 28.3%–60.7%, P = 0.11). 
Nerve damage was reported in 102 
of 346 patients (29.5%; range, 23.3%–
44.1%, P = 0.43).
Macrovascular complications were 
also highly prevalent, with 275 of 527 
patients (52.2%; range, 43.4%–60.9%, 
P = 0.42) reporting at least one com-
plication. Myocardial infarction, an-
gina or coronary artery graft surgery 
were reported in 197 of 500 patients 
(39.4%; range, 16.7%–47.4%, P = 0.24). 
Stroke or transient ischaemic attack 
were reported in 99 of 490 patients 
(20.2%; range, 10.0%–25.3%, P = 0.63), 
and 90 of 473 patients (19.0%; range, 
16.4%–25.7%, P = 0.81) had angioplasty 
or bypass surgery for peripheral vas-
cular disease.
Sixty-three of 346 patients (18.2%; 
range, 8.9%–22.7%, P = 0.53) reported 
a history of foot ulcer, and 53 of 401 
patients (13.2%; range, 4.3%–23.5%, 
P = 0.04; lowest, Sunshine; high-
est, Caulfi eld) had a current ulcer. 
Overall, 227 of 276 patients (82.2%) 
with complete information in seven 
hospitals reported at least one micro-
vascular or macrovascular complica-
tion (Box 2).
Discussion
The major fi nding of this study is that 
one in four inpatients in Melbourne 
hospitals had self-reported diabetes. 
Patients with diabetes were older and 
heavier than those without, and were 
more likely to be treated for other 
cardiovascular risk factors including 
hypertension and dyslipidaemia. Not 
surprisingly, most patients had type 2 
diabetes, and mean duration was 11.9 
years. Almost half were treated with 
insulin alone or in combination with 
oral hypoglycaemic agents. More 
than 80% of patients had at least one 
microvascular or macrovascular com-
plication. These fi ndings show that 
inpatients with diabetes are complex 
cases and have signifi cant comorbid 
conditions.
There are currently no reports of 
Australian inpatient diabetes preva-
lence, and this study fi lls that know-
ledge gap. The 26.2% prevalence of 
known diabetes in a single US hos-
pital5 is similar to our fi nding. The 
most recent International Diabetes 
Federation estimates for diabetes 
prevalence in the adult community 
are 10.0% for Australia and 10.9% for 
the US.8 In a UK survey of 206 centres, 
patients with diabetes accounted for 
5.8%–25.8% of inpatients with a me-
dian of about 15%,6 compared with 
a community prevalence of 6.6%.8 
A study of over 2 million Japanese 
inpatients found an 11.4% prevalence 
of type 2 diabetes7 compared with a 
community prevalence of 7.6%.8
The prevalence of diagnosed dia-
betes in the Victorian community is 
5.1% as assessed by National Diabetes 
Supply Scheme (NDSS) registration,9 
although this is an underestimate 
that excludes unregistered and un-
diagnosed patients. Rates within the 
Melbourne metropolitan area range 
from 2.4% in the Inner Melbourne 
local government area to 6.7% in 
Brimbank (centred on Sunshine) and 
Greater Dandenong. Diabetes preva-
lence was calculated in the four local 
government areas nearest each hospi-
tal. Assuming these account for most 
admissions, there was a strong corre-
lation between inpatient and commu-
nity prevalence of diabetes (r2 = 0.60, 
P = 0.01) (Box 3). Even assuming that 
50% of diabetes in the community is 
undiagnosed,1 these fi gures suggest 
a threefold increased hospitalisation 
risk with diabetes. Factors accounting 
for the remaining variance between 
hospitals may include differences in 
education, social class, ethnicity, pro-
vision of community diabetes sup-
port services and inpatient services 
available in each hospital.
Sunshine and Western Hospitals 
are located among the most disad-
vantaged areas in Melbourne, while 
Alfred, Caulfi eld and Sandringham 
Hospitals are in advantaged areas.10 
Consistent with the NDSS data, 
people living in the most disadvan-
taged areas have diabetes rates that 
are twice those in the most advan-
taged.11 Diabetes rates are higher in 
populations from Asian backgrounds 
than those from southern European 
and UK backgrounds,11 and > 50% 
of the residents served by Western 
and Sunshine Hospitals were born 
overseas, mainly in Asia, with up to 
60% speaking a language other than 
English at home.12
There was a signifi cant difference 
in medical management between 
hospitals, with more Western and 
Sunshine Hospital patients being 
managed by their GPs than those at 
other hospitals. There are no pub-
lished data examining the propor-
tion of patients with diabetes who 
are managed solely by GPs. However, 
long-term data suggest that increased 
exposure to specialist care lowers the 
2  Prevalence (95% CI) of any microvascular or macrovascular complication in 
inpatients with diabetes at Melbourne metropolitan hospitals
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risk of complications in patients with 
type 1 diabetes.13 Further, limited lo-
cal data suggest glycated haemoglo-
bin (HbA1c) is signifi cantly improved 
in patients managed by advanced 
skill GPs (those who have taken un-
dertaken postgraduate training in 
advanced diabetes care) supported 
by an endocrinologist and diabetes 
educator.14 However, only 55%–61% 
of patients in our study recall being 
seen by a diabetes educator and/or 
dietitian, suggesting an opportunity 
to optimise ambulatory diabetes care.
A high proportion of inpatients 
had complications, which may refl ect 
their older age and long duration of 
diabetes. Given that diabetes is the 
leading cause of end-stage kidney 
disease,15 it is surprising that only 
63% of patients recalled having a 
urine test to assess kidney damage, 
although this may refl ect recall bias. 
Eighty per cent of inpatients had their 
eyes tested and 66% had their feet 
checked. Hospital admission pro-
vides an opportunity to optimise 
glycaemic control thereby reduc-
ing microvascular complications.16 
Macrovascular complications were 
also common, being found in 52% of 
patients. Since the presence of mac-
rovascular disease increases the risk 
of future major vascular events three-
fold in patients with diabetes,17 hospi-
tal admission is also an opportunity 
to identify and treat these high-risk 
patients. For example, the admission 
may be an opportunity to optimise 
management of diabetes and other 
cardiovascular risk factors in these 
patients.
It is estimated that patients with 
diabetes account for 26% of inpatient 
expenditure in the US (US$123 billion 
in 2012),4 but there are no equivalent 
Australian data. Australian Institute 
of Health and Welfare (AIHW) 
2010–11 data suggest that diabetes 
accounted for 2.5% of all hospitalisa-
tions in Australia,18 which is consider-
ably lower than our fi nding. AIHW 
data include day cases, comprising 
58% of admissions,19 which are likely 
to dilute the prevalence of diabetes. 
Additionally, there were changes 
to diabetes coding from 2008–2012 
that decreased prevalence by 63%.19 
These factors suggest that the AIHW 
result is a gross underestimate. 
Interestingly, the coding change has 
been reversed so that it is now man-
dated that diabetes always be coded 
irrespective of admission diagnosis.
Compounding its high prevalence, 
patients with diabetes have longer 
hospital stays than those without. 
Length of stay for patients with dia-
betes was 2.8 days longer than for 
those without, irrespective of age, 
socioeconomic status, admission 
type or case complexity in a large 
English database.20 Further, diabetes 
was independently associated with 
excess bed use, especially for surgical 
admissions. We also found that gen-
eral medical inpatients with known 
diabetes stayed in hospital for 1 day 
longer than normoglycaemic patients 
without diabetes.21
The major strength of this study is 
that it encompasses > 2000 patients 
across a wide range of metropolitan 
locations. Although self-reporting 
of diabetes may be perceived as a 
weakness, cross-checking of medi-
cal records showed 98.7% accuracy. 
Nevertheless, the study has some 
limitations. Length of stay, outcomes 
and biochemical data including 
HbA1c that may now be used to di-
agnose diabetes22 were not recorded. 
Indeed, type 2 diabetes is commonly 
undiagnosed in the community,1 so 
that the reported prevalence may be 
an underestimate. Hospitals were 
studied over a 2-year period, al-
though each survey was completed 
in a single day. Importantly, there 
was no relationship between study 
date and diabetes prevalence across 
hospitals. Finally, patient numbers at 
Sandringham were small, resulting 
in wide confi dence intervals, and the 
inpatient mix in some hospitals may 
have biased results.
There are signifi cant gaps in dia-
betes education and complications 
surveillance, and hospital admis-
sion provides an opportunity to fi ll 
these gaps. Although diabetes was 
not the primary reason for admis-
sion in most patients, these fi nd-
ings have signifi cant implications 
for their short- and long-term out-
comes. Appropriate management of 
diabetes early in the admission may 
shorten length of stay and decrease 
readmission rates. Further, optimis-
ing management of diabetes and its 
complications reduces the risk of 
morbidity due to long-term compli-
cations. These fi ndings clearly have a 
bearing on Australian health expend-
iture. Ensuring that diabetes and its 
comorbid conditions are identifi ed 
and managed appropriately may re-
duce inpatient costs in the present 
admission and also decrease future 
costs related to preventable diabetes-
related complications. It is time for a 
formal Australian national inpatient 
diabetes audit that ideally captures 
biochemical data to determine its 
true prevalence and consequences. 
Such an audit would allow a compre-
hensive assessment of this high-risk 
group and permit rational planning 
to deal with shortcomings in their 
management.
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